
business
Novartis Announces 3% Q2 Sales Growth to $14.4 Billion, Fueled by New Treatments
Novartis has announced that its second-quarter sales in 2026 have exceeded expectations, driven by the introduction of new treatments.
Topic
Latest news and analysis on “Q2 2026”.

Novartis has announced that its second-quarter sales in 2026 have exceeded expectations, driven by the introduction of new treatments.

Grameenphone, Bangladesh's leading mobile operator, reported a net profit after taxes of Taka 759 crore in Q2 2026, up from the previous year despite a 3% decline in revenue.